期刊文献+

CVVHDF前后稀释对不同相对分子质量溶质清除的影响 被引量:8

Effects of different modes of dilution during CVVHDF on the removal of different solutes with different molecular weights
原文传递
导出
摘要 目的 通过建立血液净化连续静-静脉血液透析滤过(CVVHDF)模式前、后稀释方法的体外实验,探讨该模式前、后稀释法对各种不同大小的溶质分子清除效率的影响.方法 建立等容CVVHDF前、后稀释及CVVH单循环(无稀释、无透析)对照体外实验装置,比较不同相对分子质量物质钾(K^+)、肌酐(Cr)、万古霉素(vancomycin)、胰岛素(insulin)和白细胞介素-6(IL-6)的清除率,实验重复4次(n=4).结果 CVVHDF后稀释法对K^+、Cr、Vancomycin和Insulin清除率明显高于CVVHDF前稀释;CVVHDF前、后稀释对IL-6清除差异无统计学意义;对照组Insulin和IL-6实验结束时明显降低.结论 CVVHDF后稀释总体上对各种不同相对分子质量物质清除率高于前稀释,但随着相对分子质量的增大,两者间的差别缩小;对照组提示实验用滤器(AN69)对Insulin及IL-6有吸附作用. Objective To compare the rates of clearance of different solutes during continuous veno-venous haemodiafiltration (CVVHDF) between pre-dilution and post-dilution.Methods A study in vitro was carried out using model CRRT system with AN69 filter used,which was applied to perform CVVHDF for solutes clearance.The removed amounts of different solutes including potassium ion (K +),creatinine (Cr),vancomycin,insulin,and interleukin-6 (IL-6) were determined in the groups of control (without dilution),pre-dilution and post-dilution during CVVHDF at the same substitution fluid amount.Each group was repeated 4 times (n =4).Results Post-dilution mode increased K +,Cr,vancomycin and insulin clearances significantly.There was no difference in clearance of IL-6 between the pre-and post-dilution groups.In the control group,insulin and IL-6 levels were decreased extremely.Conclusions In general,the rate of clearance using post-dilution of CVVHDF is higher than that using pre-dilution.Among high molecular weight solutes,the difference in clearance is not significant.The control group demonstrates insulin and IL-6 adsorbed by the filter.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2014年第8期857-861,共5页 Chinese Journal of Emergency Medicine
基金 国家自然科学基金项目(81101451)
关键词 连续性肾替代治疗 连续静脉静脉血液透析滤过 溶质 清除率 前稀释 后稀释 相对分子质量 血滤器 Continuous renal replacement therapy Continuous veno-venous haemodiafiltration Solutes Clearance Predilution Postdilution Molecular weight Hemofilter
  • 相关文献

参考文献14

  • 1常平,宫桔云,陶少华,胡艳群,封志纯.两种置换液配方在连续性血液净化中的效果比较[J].中国血液净化,2005,4(1):45-47. 被引量:23
  • 2Ahrenholz P, Winkler RE, Ramlow W, et al. On-line hemodiafiltration with pie- and postdilutian: a comparison of efficacy [J]. IntJ Artif Organs, 1997, 20 (2): 81-90.
  • 3谢长江,刘卫江,熊旭明.两种稀释模式肾脏替代治疗MODS患者的效果比较[J].中华急诊医学杂志,2011,20(7):734-737. 被引量:9
  • 4Cerd6 J, Ronco C. Modalities of continuous renal replacement therapy: technical and clinical considerations [ J ]. Semin Dial, 2009, 22 (2): 114-122.
  • 5Park JS, Kim GH, Kang CM, et al. Regional anticoagulation with citrate is superior to systemic anticoagulation with heparin in critically ill patients undergoing continuous venovenous hemodiafiltration [J]. Korean J Intern Med, 2011, 26 (1) : 68- 75.
  • 6Awdishu L, Bouchard J. How to optimize drug delivery in renal replacement therapy [J]. Semin Dial, 2011, 24 (2): 176-182.
  • 7顾勤,朱章华,葛敏,葛卫红.万古霉素在持续性静-静脉血液滤过时的药代动力学研究[J].中国危重病急救医学,2003,15(2):114-116. 被引量:6
  • 8Yamamoto T, Yasuno N, Katada S, et al. Proposal of a pharmacokinetically optimized dosage regimen of antibiotics in patients receiving continuous hemodiafiltration [ J ]. Antimicrob Agents Chemother, 2011,55 (12) : 5804-5812.
  • 9Pea F, Viale P, Pavan F, et al. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy [J]. Clin Pharmacokinet, 2007, 46 (12) : 997-1038.
  • 10Abe M, Okada K, Ikeda K, et al. Characterization of insulin adsorption behavior of dialyzer membranes used in hemodialysis [J]. ArtifOrgaus, 2011, 35 (4): 398-403.

二级参考文献49

  • 1[1]Hirassawa H, Sugai T, Oda S, et al. Continous hemodiafiltration can remove humoral mediators from the blood stream of patients with SIRS/MODS. Abstr. Blood Purif,1997, 15:136
  • 2[2]Heering P, Morgera S, Schmitz G, et al. Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med, 1997, 23:288
  • 3[3]Kouche K,Cavadore P,Portales P, et al. Continous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNF-α and IL-6 plasma concentrations. J Neprol, 2002, 15:150
  • 4[4]Sander A,Armbruster W,Sander B, et al. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but not alter IL-6 and TNF-α plasma concentrations. Intensive Care Med, 1997, 23:878
  • 5[6]Sieberth HG,Kierdorf HP. Is cytokine removal by continuous hemofiltration feasible? Kidney Int. 1999, 56(Suppl. 72): S79
  • 6[7]Silvester W. Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis, 1997, 30 (Suppl.4): S38
  • 7[8]Sibbald WJ, Vincent JL. Round table conference on clinical trial for the treatment of sepsis. Crit Care Med, 1995, 23:394
  • 8[10]De vriese AS,Colardyn FA,Philipp JJ, et al. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol, 1999, 10: 846
  • 9[11]Morgera S,Stowinski T,Melzer C, et al. Renal replacement therapy with high-cutoff hemofilters: Impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis, 2004, 43: 444
  • 10[12]孙为民,王惠琴. 细胞因子研究方法学. 北京:人民卫生出版社,1999,178

共引文献116

同被引文献74

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部